CGP Edu

Biology Biotechnology and Its Application Biotechnological Applications in Medicine Single Correct MCQ

Published by: CGP EDU Academic Team

Published on: August 21, 2026

The genetic defect - adenosine deaminase (ADA) deficiency may be cured permanently by :-

Enzyme replacement therapy

Periodic infusion of genetically engineered lymphocytes having functional ADA cDNA

Administering adenosine deaminase activators

Introducing bone marrow cells producing ADA into cells at early embryonic stages

Text Solution

Verified by Experts

The correct answer is:

• Permanent cure for ADA deficiency requires introducing functional ADA-producing cells or genes into the patient.

• Enzyme replacement therapy or periodic infusion provides only temporary relief, not a permanent solution.

Previous Question Next Question

Get practice questions, solutions, and test series in one place.

Share your experience with this question and solution.

Send your comment, doubt, correction, or feedback to admin.

What students say about this solution

No reviews yet. Be the first to write a review.